| Financial Year |
March 31 2023 |
| Monetary Funds |
6,544,249.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
81,251,382.31 |
| Accounts Receivable |
78,912,853.41 |
| Advances to Suppliers |
20,642,035.26 |
| Other Receivables |
451,426.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,548,728.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,231,586.60 |
| Total Current Assets |
210,582,262.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
11,402,378.52 |
| Under-construction Projects |
17,312,315.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,599,358.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
299,455.89 |
| Deferred Income Tax Assets |
2,364,341.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
122,977,849.86 |
| Total Assets |
333,560,112.16 |
| Short-Term Loans |
15,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,728,790.66 |
| Accounts Payable |
33,358,544.97 |
| Accounts Received In Advance |
1,117,606.62 |
| Employee Compensation Payable |
3,916,094.88 |
| Taxes Payable |
5,220,491.33 |
| Interest Payable |
-- |
| Dividend Payable |
583,387.08 |
| Other payables |
20,273,121.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
574,089.08 |
| Sub-Total of Current Liabilities |
100,819,038.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,544,680.66 |
| Total Liabilities |
135,363,719.61 |
| Paid-In Capital(Or Share Stock) |
425,226,000.00 |
| Capital Surplus |
196,282,573.04 |
| Surplus Reserve |
1,273,672.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-431,620,561.85 |
| Minority Stockholder's Interest |
7,034,708.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
191,161,684.00 |
| Owner's Equity（Stockholder's Equity） |
198,196,392.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
333,560,112.16 |
